Table 4.
Risk factors | 2017–2018 | 2011–2017 | ||
---|---|---|---|---|
n (%) | Adjusted OR(95%CI) | n (%) | Adjusted OR(95%CI) | |
Cancer and Hematological diseases | 83 (28.7) | 3.1 (1.2–8.1) | 56 (33.1) | 0.0 (0.0-) |
WBC < 4 | 70 (24.2) | 3.5 (1.2–10.4) | 50 (29.6) | 2.3 (0.0-) |
LDH > 300 | 108 (42.7) | 7.6 (2.3–25.2) | 48 (35.6) | 1.0 (0.0-) |
AKI | 19 (6.6) | 10.1 (2.9–34.6) | 4 (2.4) | 0.0 (0.0-) |
DIC | 20 (6.9) | 56.4 (14.5–219.3) | 3 (1.8) | 1.9 (0.0-) |
Secondary bacterial infection | 72 (24.9) | 4.4 (1.6–12.4) | 13 (7.7) | 2.8 (0.0-) |
ARDS | 20 (6.9) | 32.2 (8.7–112.2) | 2 (1.2) | NA |
Respiratory Failure | 62 (21.5) | 11.7 (4.0–34.2) | 10 (5.9) | 3.2 (0.0-) |
Shock | 9 (3.1) | 23.7 (4.9–115.2) | 1 (0.6) | 0.0 (0.0-) |
MOF | 9 (3.1) | 15.5 (3.0–79.5) | 0 (0) | NA |
Glucocorticoids | 134 (46.4) | 11.6 (2.6–52.4) | 64 (37.9) | 1.5 (0.1–25.5) |
AKI acute kidney injury, DIC disseminated intravascular coagulation, ARDS acute respiratory distress syndrome, MOF multiple organ failure
WBC, white cell (109/L), LDH lactate dehydrogenase (u/L)
CI confidence interval, OR odds ratio, NA not available